Skip to main content

Evaluation of the role of infections in cancer using biological specimen banks (ERICBSB)

Objective

Prospective studies nested in biological specimen banks improve reliability and cost-efficiency of molecular epidemiological studies of the risk for cancer associated with infections, but require very large sample sizes and long follow-up. Aims: 1. To establish a network of collaborating population-based large biological specimen banks. 2. To follow-up the specimen banks by registry linkages with nationwide cancer registries to identify a study base of enrolled subjects who either develop cancer or remain alive and cancer-free. 3. To engage competent tumour biologists, microbiologists, nutritionists, immunologists, epidemiologists and bio statisticians in discussion on how to exploit the study base in the most optimal way for identification and evaluation of whether infections are risk factors for cancer. 4. To provide centralized bio statistical analysis of implemented epidemiological studies.

Funding Scheme

CON - Coordination of research actions

Coordinator

LUND UNIVERSITY
Address
University Hospital - Entrance 78
205 02 Malmoe
Sweden

Participants (9)

CENTRO DI RIFERIMENTO ONCOLOGICO
Italy
Address
Via Pedemontana Occidentale 12
33081 Aviano
FINNISH CANCER REGISTRY
Finland
Address
21B,liisankatu 21B
00170 Helsinki
GERMAN CANCER RESEARCH CENTER
Germany
Address
Im Neuenheimer Feld 242
69120 Heidelberg
ICELANDIC CANCER SOCIETY
Iceland
Address
Skogarhlid 8
Reykjavik
KAROLINSKA INSTITUTE
Sweden
Address
Karolinska Hospital
171 76 Stockholm
NATIONAL PUBLIC HEALTH INSTITUTE
Finland
Address
Aapistie 1
90101 Oulu
THE CANCER REGISTRY OF NORWAY
Norway
Address
Montebello
0310 Oslo
THE JANUS PROJECT - THE NORWEGIAN CANCER SOCIETY
Norway
Address
Rikshospitalitet
0027 Oslo
UNIVERSITY OF UMEAA
Sweden
Address
Universitetsomraadet
901 87 Umeaa